Simonsick Eleanor M, Newman Anne B, Ferrucci Luigi, Satterfield Suzanne, Harris Tamara B, Rodondi Nicolas, Bauer Douglas C
Clinical Research Branch, National Institute on Aging, Harbor Hospital, 3001 S Hanover St, Fifth Floor, Baltimore, MD 21225, USA.
Arch Intern Med. 2009 Nov 23;169(21):2011-7. doi: 10.1001/archinternmed.2009.392.
Health risks associated with subclinical hypothyroidism in older adults are unclear. Our objective was to compare the functional mobility of people aged 70 to 79 years by thyroid function categorized by thyrotropin (TSH) level as euthyroid (>or=0.4 to <4.5 mIU/L), mild subclinical hypothyroid (>or=4.5 to <7.0 mIU/L), or moderate subclinical hypothyroid (>or=7.0 to <or=20.0 mIU/L with a normal free thyroxine level) cross-sectionally and over 2 years.
A total of 2290 community-dwelling residents participating in the year 2 clinic visit (July 1998-June 1999) of the Health, Aging, and Body Composition (Health ABC) Study, who had measured TSH level, had the capacity to walk 20 m unaided, and were not taking thyroid medication or had TSH levels consistent with hyperthyroidism or hypothyroidism. Main outcome measures included self-reported and performance-based measures of mobility (usual and rapid gait speed and endurance walking ability) assessed at study baseline (year 2) and 2 years later.
In age- and sex-adjusted analyses, the mild subclinical hypothyroid group (vs the euthyroid group) demonstrated better mobility (faster mean usual and rapid gait speed [1.20 vs 1.15 m/s and 1.65 vs 1.56 m/s, respectively; P < .001] and had a higher percentage of those with good cardiorespiratory fitness and reported walking ease [39.2% vs 28.0% and 44.7% vs 36.5%, respectively; P < .001]). After 2 years, persons with mild subclinical hypothyroidism experienced a similar decline as the euthyroid group but maintained their mobility advantage. Persons with moderate subclinical hypothyroidism had similar mobility and mobility decline as the euthyroid group.
Generally, well-functioning 70- to 79-year-old individuals with subclinical hypothyroidism do not demonstrate increased risk of mobility problems, and those with mild elevations in TSH level show a slight functional advantage.
老年人亚临床甲状腺功能减退相关的健康风险尚不清楚。我们的目的是通过按促甲状腺激素(TSH)水平分类的甲状腺功能,对70至79岁人群的功能活动能力进行横断面比较,并随访2年,TSH水平分类为甲状腺功能正常(≥0.4至<4.5 mIU/L)、轻度亚临床甲状腺功能减退(≥4.5至<7.0 mIU/L)或中度亚临床甲状腺功能减退(≥7.0至≤20.0 mIU/L且游离甲状腺素水平正常)。
共有2290名参与健康、衰老和身体成分(Health ABC)研究第2年诊所访视(1998年7月至1999年6月)的社区居民,他们测量了TSH水平,有能力独立行走20米,且未服用甲状腺药物或TSH水平与甲状腺功能亢进或减退一致。主要结局指标包括在研究基线(第2年)和2年后评估的自我报告和基于表现的活动能力指标(通常和快速步态速度以及耐力行走能力)。
在年龄和性别调整分析中,轻度亚临床甲状腺功能减退组(与甲状腺功能正常组相比)表现出更好活动能力(平均通常和快速步态速度更快[分别为1.20 vs 1.15 m/s和1.65 vs 1.56 m/s;P <.001],且心肺功能良好和报告行走轻松的比例更高[分别为39.2% vs 28.0%和44.7% vs 36.5%;P <.001])。2年后,轻度亚临床甲状腺功能减退者的下降情况与甲状腺功能正常组相似,但仍保持其活动能力优势。中度亚临床甲状腺功能减退者的活动能力及活动能力下降情况与甲状腺功能正常组相似。
一般来说,功能良好的70至79岁亚临床甲状腺功能减退个体并未表现出活动能力问题风险增加,TSH水平轻度升高者显示出轻微的功能优势。